Tempest Therapeutics (TPST) AGM 2026 summary

Opening remarks and agenda

• Meeting reconvened from July 27, 2026, and called to order at 12:01 p.m. Eastern; formal business was to follow procedural remarks.

• One proposal was scheduled for stockholder consideration.

Corporate governance

• Broadridge Financial Solutions representative Ms. Skoglund was appointed Inspector of Election, took the customary oath, and was responsible for voter qualifications, ballot acceptance, and vote tallying.

• Each common share carried one vote; voting was conducted by proxy and electronic ballot.

Overview of voting outcomes

• Proxies covered 11,004,101 of 14,806,997 outstanding shares as of the May 28, 2026 record date, or 74.3%, establishing a quorum.

• The Inspector reported insufficient votes in favor of Proposal One; the meeting was adjourned to allow stockholders more time to consider it.

• The meeting will reconvene November 12, 2026, at 2:00 p.m. Eastern at the same virtual meeting link.